{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:44:16Z","timestamp":1785818656280,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.vaccine.2013.05.059","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T23:30:36Z","timestamp":1369870236000},"page":"3353-3360","source":"Crossref","is-referenced-by-count":80,"title":["Deciphering the protective role of adaptive immunity to CHIKV\/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model"],"prefix":"10.1016","volume":"31","author":[{"given":"Haiyan","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subash C.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy F.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan T.","family":"Stinchcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos D.","family":"Partidos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E.","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.05.059_bib0005","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1099\/vir.0.82858-0","article-title":"Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus","volume":"88","author":"Powers","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0010","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1371\/journal.pmed.0030263","article-title":"Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak","volume":"3","author":"Schuffenecker","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.trstmh.2004.03.013","article-title":"Tracking the re-emergence of epidemic chikungunya virus in Indonesia","volume":"99","author":"Laras","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0020","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1473-3099(07)70091-9","article-title":"Chikungunya epidemic in India: a major public-health disaster","volume":"7","author":"Mavalankar","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0025","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3201\/eid1705.101873","article-title":"Chikungunya virus, southeastern France","volume":"17","author":"Grandadam","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0030","doi-asserted-by":"crossref","first-page":"e18860","DOI":"10.1371\/journal.pone.0018860","article-title":"Transmission potential of chikungunya virus and control measures: the case of Italy","volume":"6","author":"Poletti","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(07)70107-X","article-title":"Chikungunya, an epidemic arbovirosis","volume":"7","author":"Pialoux","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0040","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(11)60281-X","article-title":"Chikungunya: a re-emerging virus","volume":"379","author":"Burt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0045","doi-asserted-by":"crossref","first-page":"e1446","DOI":"10.1371\/journal.pntd.0001446","article-title":"Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia","volume":"6","author":"Dupuis-Maguiraga","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrmicro2368","article-title":"Biology and pathogenesis of chikungunya virus","volume":"8","author":"Scwartz","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0055","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0060","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/600381","article-title":"Prophylaxis and therapy for chikungunya virus infection","volume":"200","author":"Couderc","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0065","doi-asserted-by":"crossref","first-page":"13005","DOI":"10.1128\/JVI.01780-12","article-title":"Longitudinal analysis of the human antibody response to chikungunya virus infection: implications for serodiagnosis and vaccine development","volume":"86","author":"Kam","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0070","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/infdis\/jis033","article-title":"Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection","volume":"205","author":"Kam","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0075","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/emmm.201200213","article-title":"Early neutralizing IgG response to chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein","volume":"4","author":"Kam","year":"2012","journal-title":"EMBO Mol Med."},{"key":"10.1016\/j.vaccine.2013.05.059_bib0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/infdis\/jis674","article-title":"Use of human monoclonal antibodies to treat chikungunya virus infection","volume":"207","author":"Fric","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0085","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/j.vaccine.2011.01.076","article-title":"Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling","volume":"29","author":"Partidos","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0090","doi-asserted-by":"crossref","first-page":"e1002142","DOI":"10.1371\/journal.ppat.1002142","article-title":"Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism","volume":"7","author":"Plante","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0095","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1016\/j.vaccine.2011.03.089","article-title":"Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection","volume":"29","author":"Holzer","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0100","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1016\/j.vaccine.2012.04.099","article-title":"Cross-protective immunity against o\u2018nyong-nyong virus afforded by a novel recombinant chikungunya vaccine","volume":"30","author":"Partidos","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0105","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.4049\/jimmunol.0900255","article-title":"Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response","volume":"184","author":"Hoarau","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/infdis\/jiq006","article-title":"The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation","volume":"204","author":"Wauquier","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4049\/jimmunol.1202177","article-title":"A pathogenic role for CD4+ T cells during chikungunya virus infection in mice","volume":"190","author":"Teo","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0120","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1016\/j.vaccine.2008.07.054","article-title":"Chimeric alphavirus vaccine candidates for chikungunya","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0264-410X(86)90003-4","article-title":"Development of an attenuated strain of chikungunya virus for use in vaccine production","volume":"3","author":"Levitt","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4049\/jimmunol.107.3.643","article-title":"Production and evaluation of a formalin-killed Chikungunya vaccine","volume":"107","author":"Harrison","year":"1971","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0135","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.vaccine.2009.02.062","article-title":"Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus","volume":"27","author":"Tiwari","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0140","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1016\/j.vaccine.2008.03.060","article-title":"Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus","volume":"26","author":"Muthumani","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0145","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm.2105","article-title":"A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection","volume":"16","author":"Akahata","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0150","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2011.01.108","article-title":"A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0155","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1128\/JVI.01860-12","article-title":"A chimeric vesiculo\/alphavirus is an effective alphavirus vaccine","volume":"87","author":"Chattopadhyay","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.virol.2008.04.020","article-title":"IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells","volume":"377","author":"Volkova","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0165","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.0801974","article-title":"A protective role for dengue virus-specific CD8+ T cells","volume":"182","author":"Yauch","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0170","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.4049\/jimmunol.1001709","article-title":"CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination","volume":"185","author":"Yauch","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0175","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4049\/jimmunol.1102124","article-title":"Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells","volume":"188","author":"Zompi","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0180","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1016\/j.vaccine.2012.09.007","article-title":"Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine","volume":"30","author":"Das","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0185","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1084\/jem.20090851","article-title":"Type I IFN controls chikungunya virus via its action on nonhematopoietic cells","volume":"207","author":"Schilte","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0190","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.4049\/jimmunol.0904181","article-title":"Active infection of human blood monocytes by chikungunya virus triggers an innate immune response","volume":"184","author":"Her","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.05.059_bib0195","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1128\/JVI.72.6.5146-5153.1998","article-title":"Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages","volume":"72","author":"Linn","year":"1998","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13006610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13006610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T00:23:08Z","timestamp":1688257388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13006610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":39,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0264410X13006610"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}